Wellington Management Group LLP Sells 18,885 Shares of Phibro Animal Health Corporation $PAHC

Wellington Management Group LLP cut its stake in Phibro Animal Health Corporation (NASDAQ:PAHC) by 23.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 63,113 shares of the company’s stock after selling 18,885 shares during the period. Wellington Management Group LLP owned about 0.16% of Phibro Animal Health worth $1,348,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Phibro Animal Health in the fourth quarter worth about $29,000. National Bank of Canada FI bought a new position in shares of Phibro Animal Health in the first quarter worth about $30,000. Lazard Asset Management LLC grew its holdings in shares of Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock worth $34,000 after purchasing an additional 1,589 shares during the last quarter. Virtus Fund Advisers LLC bought a new position in shares of Phibro Animal Health in the fourth quarter worth about $69,000. Finally, Aquatic Capital Management LLC bought a new position in shares of Phibro Animal Health in the fourth quarter worth about $69,000. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Stock Performance

PAHC stock opened at $37.07 on Monday. The firm has a market cap of $1.50 billion, a price-to-earnings ratio of 31.42, a PEG ratio of 0.54 and a beta of 0.88. The firm has a 50-day simple moving average of $29.34 and a two-hundred day simple moving average of $24.45. Phibro Animal Health Corporation has a one year low of $16.16 and a one year high of $38.83. The company has a debt-to-equity ratio of 2.46, a quick ratio of 1.25 and a current ratio of 2.76.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 27th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.52 by $0.05. The business had revenue of $378.70 million during the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, equities analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.3%. Phibro Animal Health’s dividend payout ratio is 40.68%.

Wall Street Analysts Forecast Growth

PAHC has been the subject of a number of research reports. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $25.00 to $35.00 in a research note on Monday, July 7th. Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a research note on Thursday. BNP Paribas raised shares of Phibro Animal Health to a “hold” rating in a research note on Monday, June 16th. Bank of America upped their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research note on Friday. Finally, Wall Street Zen raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus target price of $28.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.